Tempus Stock
Cancer battling operating system
About Tempus Stock
Tempus is a technology company that has built an operating system to battle cancer. It is on a mission to redefine how genomic data is used in a clinical setting. Their goal is for each patient to benefit from the treatment of others who came before by enabling physicians to deliver personalized cancer care for patients through interactive analytical and machine learning platform.
Investors
Baillie Gifford
Spotify, AUTO1 Group, Ginkgo Bioworks, Carbon, Indigo AG, HeartFlow, Tempus, Thumbtack, HelloFresh, Anaplan
Franklin Templeton
New Enterprise Associates
Jet, Bloom Energy, Opendoor, Letgo, Databricks, Robinhood, Automation Anywhere, 23andMe, Box, Good Technology
Novo Holdings
Revolution
Tempus, Sweetgreen, Aura, DraftKings, Optoro, BigCommerce, Tala, Uptake Technologies, Scopely, Revolution Foods
T. Rowe Price
Cruise, Airbnb, Magic Leap, Rivian Automotive, Deliveroo, Pure Storage, LivingSocial, Cloudera, Ginkgo Bioworks, Toast
Funding History
| September 2015 | $10.0M |
|---|---|
| June 2016 | $10.0M |
| November 2016 | $10.0M |
| April 2017 | $30.0M |
| September 2017 | $70.0M |
| March 2018 | $80.0M |
| August 2018 | $110M |
| May 2019 | $200M |
Management
Founder & Chief Executive Officer
Eric Lefkofsky
Chief Technology Officer
Shane Folley
Chief Operating Officer
Ryan Fukushima
Chief Medical Officer
Gary Palmer
Chief Financial Officer
Vanessa Rollings
Chief Commercial Officer
Mike Yasiejko
Chief Strategy Officer
Marc Yoskowitz
Chief Science Officer
Kevin White
Press
TechCrunch - May, 31 2019
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Tempus or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
